Mr Steven Michael Gibson
Mr Steven Michael Gibson was appointed in a total of 7 companies and resigned from 0 of these appointments.
Role
Director
Country Of Residence
England
Nationality
British
Date of Birth
September 1982
Occupation
Accountant
Active
4
Resigned
0
Dissolved
3
Other
0
Total
7
Companies
| Company | Timeline | Status | |
| Delta Diagnostics (UK) Ltd Director • Accountant | 11 Dec 2023←1 Year 1 Month→4 Feb 2025 | Dissolved | |
| Novacyt UK Holdings Limited Director • Director | 20 Sep 2023←1 Year 11 Months→Current | Active | |
| Primer Design Limited Director • Director | 20 Sep 2023←1 Year 11 Months→Current | Active | |
| It-Is International Limited Director • Director | 20 Sep 2023←1 Year 11 Months→Current | Active | |
| Lab 21 Healthcare Limited Director • Director | 20 Sep 2023←1 Year 11 Months→Current | Active | |
| Microgen Bioproducts Limited Director • Director | 20 Sep 2023←1 Year 6 Months→1 Apr 2025 | Dissolved | |
| Biotec Laboratories Limited Director • Director | 20 Sep 2023←5 Months→20 Feb 2024 | Dissolved | |
Mutual People
- James Martin McCarthyLab 21 Healthcare Limited, Novacyt UK Holdings Limited, Microgen Bioproducts Limited, and 3 more are mutual companies.
- Mr David James AllmondNovacyt UK Holdings Limited, It-Is International Limited, Microgen Bioproducts Limited, and 3 more are mutual companies.
- Mr Anthony William DyerBiotec Laboratories Limited, Primer Design Limited, Microgen Bioproducts Limited, and 3 more are mutual companies.
- Mr Graham David MullisBiotec Laboratories Limited, Primer Design Limited, It-Is International Limited, and 2 more are mutual companies.
- Susan Day LowtherLab 21 Healthcare Limited, Microgen Bioproducts Limited and Biotec Laboratories Limited are mutual companies
- Mrs Madeleine Elizabeth KennedyLab 21 Healthcare Limited and Biotec Laboratories Limited are mutual companies.
Financials, Credit Activity, Owners, and more
Completely understand the businesses you work with
Make key decisions on clients and suppliers faster, discover leads and connect with decision makers, and easily monitor opportunities that get better through time
